AUEBLISS- lidocaine cream 
Jag Alliance, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredient

Lidocaine HCl 5%

Purpose

Topical analgesic/Anesthetic

Uses

For the temporary relief of minor pain, irritation and itching

Warnings

For external use only.
When using this product Avoid contact with eyes.
Do not apply to wounds or damaged, broken or irritated skin
Stop use and ask a doctor If• Condition worsens. • Irritation develops. Redness appears. • Symptoms persist for more than 7 days or clear up and occurs again within a few days.

Keep out of reach of children If product is swallowed, get medical help or contact a Poison Control Center right away. Emergency Number: 1-800-222-1222

IF PREGNANT OR BREASTFEEDING, ask a heath professional before use

Directions

Adults and children over 12 years:
• Apply a thin layer to affected area every 6 to 8 hours.
• Wash hands with soap and water immediately after use.
• Children 12 years or younger: ask a doctor.

Other Information

Store at 15•-30• C (59'-86' F).

Inactive ingredients

Aqua, Caprylic/Capric Triglyceride, Butylene Glycol, Ethoxydiglycol, Ammonium AcryloyldimethyltaurateNP Copolymer, Squalane, Aloe Barbadensis (Aloe Vera) Leaf Juice, Allantoin, Tocopherol (Vitamin E), Persea Gratissima (Avocado) Oil, Hydroxyethyl Acrylate, Sodium Acryloyldimethyl Tau rate Copolymer, Polyacrylate Crosspolymer-6, Phenoxyethanol, Xanthan Gum, Ethylhexylglycerin, Lecithin.

Questions and comments 

855-700-0660

Product label

image description

AUEBLISS 
lidocaine cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73143-002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE5 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG)  
SQUALANE (UNII: GW89575KF9)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
ALLANTOIN (UNII: 344S277G0Z)  
TOCOPHEROL (UNII: R0ZB2556P8)  
AVOCADO OIL (UNII: 6VNO72PFC1)  
2-HYDROXYETHYL ACRYLATE (UNII: 25GT92NY0C)  
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (100000 MPA.S AT 1.5%) (UNII: 86FQE96TZ4)  
AMMONIUM ACRYLOYLDIMETHYLTAURATE, DIMETHYLACRYLAMIDE, LAURYL METHACRYLATE AND LAURETH-4 METHACRYLATE COPOLYMER, TRIMETHYLOLPROPANE TRIACRYLATE CROSSLINKED (45000 MPA.S) (UNII: Q7UI015FF9)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
XANTHAN GUM (UNII: TTV12P4NEE)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
TRICAPRIN (UNII: O1PB8EU98M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73143-002-0156 g in 1 TUBE; Type 0: Not a Combination Product01/05/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34801/05/2023
Labeler - Jag Alliance, LLC (081456767)

Revised: 1/2023
Document Id: f183f9bf-558b-4a99-e053-2995a90a0878
Set id: d7e394b6-3e88-445b-82eb-3b89d70eb8b3
Version: 1
Effective Time: 20230105
 
Jag Alliance, LLC